南美洲和中美洲分子诊断市场预测至 2030 年 - 区域分析 - 按疾病领域（肿瘤、传染病、基因检测、心脏病、免疫系统疾病等）、技术（聚合酶链式反应、等温核酸扩增技术、DNA）测序和下一代测序、DNA 微阵列、原位杂交等）、产品和服务（检测和试剂盒、仪器以及服务和软件）以及最终用户（医院和诊所、诊断实验室、研究和学术机构） ， 和别的）
No. of Pages: 102 | Report Code: TIPRE00026719 | Category: Life Sciences
No. of Pages: 102 | Report Code: TIPRE00026719 | Category: Life Sciences
分子诊断技术和平台正在应用于解剖和临床病理学的所有领域。与疾病相关的 DNA 或 RNA 序列，包括单核苷酸多态性、缺失、重排和插入，可以在分子诊断测试中检测到。 COVID-19出现后，分子诊断得到了进一步的改进。传统上，CT扫描、血液学检测和RT-PCR用于检测。随着 2020 年 COVID-19 病例的快速增长，对快速、精确的检测平台的需求激增，以克服传统检测的缺点。计算机断层扫描 (CT) 是一种成本密集型检查，可能并非所有医院都能提供，无法检测无症状患者的病毒感染和其他疾病。广泛使用的RT-PCR也耗时且昂贵，并且无法检测感染早期的低病毒载量。因此，研究人员开发了检测 SARS-CoV-2 的新方法，这种方法更快、更具成本效益。逆转录环介导等温扩增 (RT-LAMP)、基于微阵列的检测、基于适体的诊断、SHERLOCK、SHERLOCKv2、FET 生物传感器、基于细胞的电位诊断和分子印迹技术是新型分子诊断的一些例子为 COVID-19 诊断开发的技术。在过去几年中，FDA 报告表明分子检测、抗原依赖性检测和血清学检测方面的进步已得到批准。不同国家的科学界为管理 COVID-19 大流行和降低死亡率而共同努力，使整个分子工具和诊断领域受益，这可能会在未来为分子诊断市场创造重大机遇。
南美洲的分子诊断市场中美洲分为阿根廷、巴西和南美其他地区。中美洲。该地区的市场增长归因于人口老龄化、诊断市场的增长以及医疗器械行业主要参与者的不断增加的举措。此外，慢性病的流行需要有前景的诊断测试方案，这有助于该地区的市场增长。
南美洲和南美洲中美洲分子诊断市场分为疾病区域、技术、产品和服务、最终用户和国家。中美洲分子诊断市场分为传染病、肿瘤学、基因检测、心脏病、免疫系统疾病等。传染病领域的南美和南美地区规模最大。 2022 年中美洲分子诊断市场份额。中美洲分子诊断市场细分为聚合酶链反应（PCR）、原位杂交、等温核酸扩增技术（INAAT）、DNA测序和下一代测序（NGS）、DNA微阵列等。聚合酶链式反应 (PCR) 领域在 South & 地区注册最多。 2022 年中美洲分子诊断市场份额。聚合酶链式反应 (PCR) 进一步细分为 RT-PCR、qPCR、多重 PCR 等。
根据产品和服务，South &中美洲分子诊断市场分为检测和试剂盒、仪器、服务和软件。检测和试剂盒领域注册了最大的 South & 。 2022 年中美洲分子诊断市场份额。
根据最终用户，南美洲和南美洲的市场份额中美洲分子诊断市场分为诊断实验室、医院和诊所、研究和学术机构等。诊断实验室领域拥有最大的南美和南美地区规模。 2022 年中美洲分子诊断市场份额。
按国家/地区划分，南美和北美洲中美洲分子诊断市场分为巴西、阿根廷和南美其他地区。中美洲。巴西在南部和南部地区占据主导地位。 2022 年中美洲分子诊断市场。
Abbott Laboratories、bioMerieux SA、Danaher、F. Hoffmann-La Roche Ltd、Illumina Inc、Novartis AG、Qiagen NV、Siemens Healthineers AG 和 Thermo Fisher Scientific Inc. 是在南部和南部地区运营的一些领先公司。中美洲分子诊断市场。
Strategic insights for South & Central America Molecular Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 1,221.28 Million |
| Market Size by 2030 | US$ 2,679.14 Million |
| Global CAGR (2022 - 2030) | 10.3% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By 疾病领域
|
| Regions and Countries Covered | 南美洲和中美洲
|
| Market leaders and key company profiles |
The regional scope of South & Central America Molecular Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South & Central America Molecular Diagnostics Market is valued at US$ 1,221.28 Million in 2022, it is projected to reach US$ 2,679.14 Million by 2030.
As per our report South & Central America Molecular Diagnostics Market, the market size is valued at US$ 1,221.28 Million in 2022, projecting it to reach US$ 2,679.14 Million by 2030. This translates to a CAGR of approximately 10.3% during the forecast period.
The South & Central America Molecular Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Molecular Diagnostics Market report:
The South & Central America Molecular Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Molecular Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Molecular Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South & Central America Molecular Diagnostics Market
